| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $19.1M | — | +2.9% |
| Gross Profit | $12.5M | — | +0.1% |
| R&D Expense | $2.3M | — | -7.8% |
| SG&A Expense | $4.2M | — | +8.6% |
| Operating Income | -$10.5M | — | -0.5% |
| Pre-tax Income | -$12.2M | — | -8.9% |
| Income Tax | $60K | — | +15.4% |
| Net Income | -$12.3M | — | -9.0% |
| EPS (Basic) | -$0.21 | — | +16.0% |
| EPS (Diluted) | -$0.21 | — | +16.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $39.5M | -22.2% | -7.7% |
| Accounts Receivable | $9.7M | -6.1% | -8.0% |
| Inventory | $12.2M | +10.9% | -9.8% |
| Current Assets | $64.3M | -14.9% | -7.8% |
| Total Assets | $69.9M | -14.2% | -9.5% |
| Current Liabilities | $17.8M | -0.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.2M | — | -14.9% |
| Capital Expenditures | $119K | — | +271.9% |
| Investing Cash Flow | $190K | — | +37.7% |
| Financing Cash Flow | -$298K | — | -156.9% |
| Free Cash Flow | -$11.3M | — | -15.7% |
| +7.8% |
| Long-term Debt | $55.9M | +0.4% | +35.4% |
| Total Liabilities | $75.1M | -0.0% | +27.0% |
| Stockholders' Equity | -$5.2M | -182.4% | -128.7% |